Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
CA ›
CAMZAVA
Trademark search for:
CAMZAVA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-06-16 — Application filed
2020-06-19 — Application filed
2020-07-13 — Application filed
2020-09-18 — Assigned to examiner
2020-09-25 — Final disposition recorded
2020-09-25 — Final disposition recorded
2020-09-25 — Final disposition recorded
2020-11-02 — Approved for pub - principal register
2020-11-18 — Notification of notice of publication e-mailed
2020-12-08 — Published for opposition
2020-12-08 — Official gazette publication confirmation e-mailed
2021-02-02 — Noa e-mailed - sou required from applicant
2021-07-14 — Sou teas extension received
2021-07-14 — Sou extension 1 filed
2021-07-14 — Sou extension 1 granted
2021-07-16 — Notice of approval of extension request e-mailed
2021-12-22 — Sou teas extension received
2021-12-22 — Sou extension 2 filed
2021-12-22 — Sou extension 2 granted
2021-12-24 — Notice of approval of extension request e-mailed
2022-08-01 — Sou teas extension received
2022-08-01 — Sou extension 3 filed
2022-08-01 — Sou extension 3 granted
2022-08-03 — Notice of approval of extension request e-mailed
2023-02-02 — Sou extension 4 filed
2023-02-06 — Sou extension received with teas petition
2023-02-06 — Notice of revival - e-mailed
2023-02-06 — Petition to revive-granted
2023-02-06 — Teas petition to revive received
2023-03-27 — Case assigned to intent to use paralegal
2023-03-29 — Sou extension 4 granted
2023-03-30 — Notice of approval of extension request e-mailed
2023-09-04 — Application abandoned
2023-09-04 — Final status recorded
2023-09-05 — Application abandoned
Owner Information
Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc.
Correspondent
Mark A. Paskar BRYAN CAVE LEIGHTON PAISNER LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
